DK4221709T3 - Imidazopiperazin-hæmmere af transkriptionsaktiverende proteiner - Google Patents

Imidazopiperazin-hæmmere af transkriptionsaktiverende proteiner

Info

Publication number
DK4221709T3
DK4221709T3 DK21876484.3T DK21876484T DK4221709T3 DK 4221709 T3 DK4221709 T3 DK 4221709T3 DK 21876484 T DK21876484 T DK 21876484T DK 4221709 T3 DK4221709 T3 DK 4221709T3
Authority
DK
Denmark
Prior art keywords
imidazopiperazine
transcription
inhibitors
activating proteins
proteins
Prior art date
Application number
DK21876484.3T
Other languages
Danish (da)
English (en)
Inventor
Kang Le
Michael Soth
Philip Jones
Jason Cross
Timothy Mcafoos
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Application granted granted Critical
Publication of DK4221709T3 publication Critical patent/DK4221709T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK21876484.3T 2020-10-02 2021-09-30 Imidazopiperazin-hæmmere af transkriptionsaktiverende proteiner DK4221709T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063086728P 2020-10-02 2020-10-02
PCT/US2021/052898 WO2022072648A1 (en) 2020-10-02 2021-09-30 Imidazopiperazine inhibitors of transcription activating proteins

Publications (1)

Publication Number Publication Date
DK4221709T3 true DK4221709T3 (da) 2026-04-07

Family

ID=80950902

Family Applications (1)

Application Number Title Priority Date Filing Date
DK21876484.3T DK4221709T3 (da) 2020-10-02 2021-09-30 Imidazopiperazin-hæmmere af transkriptionsaktiverende proteiner

Country Status (14)

Country Link
US (2) US12559497B2 (cg-RX-API-DMAC7.html)
EP (1) EP4221709B1 (cg-RX-API-DMAC7.html)
JP (1) JP7865951B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230080441A (cg-RX-API-DMAC7.html)
CN (1) CN116261454A (cg-RX-API-DMAC7.html)
AU (1) AU2021355480B2 (cg-RX-API-DMAC7.html)
CA (1) CA3193745A1 (cg-RX-API-DMAC7.html)
DK (1) DK4221709T3 (cg-RX-API-DMAC7.html)
ES (1) ES3068299T3 (cg-RX-API-DMAC7.html)
IL (1) IL301707A (cg-RX-API-DMAC7.html)
MX (1) MX2023003785A (cg-RX-API-DMAC7.html)
PL (1) PL4221709T3 (cg-RX-API-DMAC7.html)
PT (1) PT4221709T (cg-RX-API-DMAC7.html)
WO (1) WO2022072648A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7777131B2 (ja) 2020-10-02 2025-11-27 ボード オブ レジェンツ,ザ ユニバーシティ オブ テキサス システム 転写活性化タンパク質のイミダゾピペラジン阻害剤
KR20230080441A (ko) 2020-10-02 2023-06-07 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 전사 활성화 단백질의 이미다조피페라진 억제제
AU2024331409A1 (en) * 2023-08-30 2026-03-12 Oncopia Therapeutics, Inc. D/B/A Sk Life Science Labs Compounds and compositions as cbp/p300 degraders and uses thereof
WO2026128761A1 (en) 2024-12-11 2026-06-18 Nexo Therapeutics, Inc. Covalent p300 inhibitor compounds

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2270143T3 (es) 2002-08-07 2007-04-01 Novartis Ag Compuestos organicos como agentes para el tratamiento de condiciones mediadas por aldosterona.
US20070004736A1 (en) 2002-11-22 2007-01-04 Keiji Kubo Imidazole derivative, process for producing the same, and use
WO2007139992A2 (en) 2006-05-26 2007-12-06 Novartis Ag ALDOSTERONE SYNTHASE AND/OR 11β-HYDROXYLASE INHIBITORS
US7943617B2 (en) 2006-11-27 2011-05-17 Bristol-Myers Squibb Company Heterobicyclic compounds useful as kinase inhibitors
AU2007337659A1 (en) * 2006-12-22 2008-07-03 Actelion Pharmaceuticals Ltd. 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives
US8859538B2 (en) 2007-06-21 2014-10-14 Cara Therapeutics, Inc. Uses of substituted imidazoheterocycles
EA201000046A1 (ru) 2007-06-21 2011-02-28 Кара Терапеутикс, Инк. Замещенные имидазогетероциклы
CN101417999A (zh) 2007-10-25 2009-04-29 上海恒瑞医药有限公司 哌嗪类衍生物,其制备方法及其在医药上的应用
CN101468988A (zh) 2007-12-26 2009-07-01 上海恒瑞医药有限公司 哌嗪类衍生物,其制备方法及其在医药上的应用
KR20110036069A (ko) 2008-06-25 2011-04-06 액테리온 파마슈티칼 리미티드 5,6,7,8-테트라히드로-이미다조[1,5-a]피라진 화합물
WO2011092120A1 (en) 2010-01-29 2011-08-04 Nerviano Medical Sciences S.R.L. 6,7- dihydroimidazo [1,5-a] pyrazin-8 (5h) - one derivatives as protein kinase modulators
CN102372716A (zh) 2010-08-09 2012-03-14 江苏恒瑞医药股份有限公司 酞嗪酮类衍生物、其制备方法及其在医药上的应用
WO2013050446A1 (en) 2011-10-07 2013-04-11 Nerviano Medical Sciences S.R.L. SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1(2H)-ONE DERIVATIVES AS KINASES INHIBITORS
CN103087067A (zh) 2012-08-02 2013-05-08 盛世泰科生物医药技术(苏州)有限公司 作为二肽基酶抑制剂的化合物及其组合物,以及它们的用途
WO2014062548A1 (en) 2012-10-18 2014-04-24 Bristol-Myers Squibb Company Tetrahydroimdidazopyrazine derivatives as cgrp receptor antagonists
US9371282B2 (en) * 2013-05-17 2016-06-21 Centrexion Therapeutics Corporation Somatostatin receptor subtype 4 (SSTR4) agonists
CA2915163A1 (en) 2013-06-12 2014-12-18 Proximagen Limited New therapeutic uses of enzyme inhibitors
CN106456628A (zh) * 2014-03-19 2017-02-22 无限药品股份有限公司 用于治疗PI3K‑γ介导的障碍的杂环化合物
CN107108512B (zh) 2014-10-10 2021-05-04 基因泰克公司 治疗性化合物及其用途
EP3632915A1 (en) * 2014-11-27 2020-04-08 Genentech, Inc. 4,5,6,7-tetrahydro-1 h-pyrazolo[4,3-c]pyridin-3-amine compounds as cbp and/or ep300 inhibitors
MA41338B1 (fr) 2015-01-16 2019-07-31 Hoffmann La Roche Composés de pyrazine pour le traitement de maladies infectieuses
GB201506658D0 (en) 2015-04-20 2015-06-03 Cellcentric Ltd Pharmaceutical compounds
GB201506660D0 (en) 2015-04-20 2015-06-03 Cellcentric Ltd Pharmaceutical compounds
AU2017252276A1 (en) 2016-04-18 2018-11-15 Celgene Quanticel Research, Inc. Therapeutic compounds
MA45146A (fr) 2016-05-24 2021-03-24 Constellation Pharmaceuticals Inc Dérivés de pyrazolopyridine pour le traitement du cancer
WO2017205536A2 (en) 2016-05-24 2017-11-30 Genentech, Inc. Therapeutic compounds and uses thereof
CA3095367A1 (en) 2018-03-29 2019-10-03 Board Of Regents, The University Of Texas System Imidazopiperazine inhibitors of transcription activating proteins
WO2019195846A1 (en) 2018-04-06 2019-10-10 Board Of Regents, The University Of Texas System Imidazopiperazinone inhibitors of transcription activating proteins
JP7777131B2 (ja) 2020-10-02 2025-11-27 ボード オブ レジェンツ,ザ ユニバーシティ オブ テキサス システム 転写活性化タンパク質のイミダゾピペラジン阻害剤
KR20230080441A (ko) 2020-10-02 2023-06-07 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 전사 활성화 단백질의 이미다조피페라진 억제제

Also Published As

Publication number Publication date
IL301707A (en) 2023-05-01
EP4221709A4 (en) 2024-10-02
ES3068299T3 (en) 2026-05-28
CA3193745A1 (en) 2022-04-07
AU2021355480B2 (en) 2026-03-05
US20230312588A1 (en) 2023-10-05
EP4221709A1 (en) 2023-08-09
MX2023003785A (es) 2023-04-26
US12559497B2 (en) 2026-02-24
PL4221709T3 (pl) 2026-08-10
JP7865951B2 (ja) 2026-05-26
EP4221709B1 (en) 2026-01-21
CN116261454A (zh) 2023-06-13
KR20230080441A (ko) 2023-06-07
AU2021355480A1 (en) 2023-05-04
US20260132138A1 (en) 2026-05-14
JP2023544173A (ja) 2023-10-20
AU2021355480A9 (en) 2024-09-12
WO2022072648A1 (en) 2022-04-07
PT4221709T (pt) 2026-04-24

Similar Documents

Publication Publication Date Title
DK4061812T3 (da) Forbindelser som er nyttige som inhibitorer af heliosprotein
EP4069212A4 (en) INHIBITORS OF HIF-2ALPHA
EP4452974A4 (en) RAS ONCOPROTEIN INHIBITORS
IL287787A (en) Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof
IL287795A (en) Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof
EP4216951A4 (en) KRAS G12D INHIBITORS
DK4146348T3 (da) Inhibitorer af nek7-kinase
EP4225364A4 (en) Prefusion-stabilized hmpv f proteins
IL288996A (en) Aminopyrimidine amide autophagy inhibitors and methods of use thereof
IL277778B (en) Bcl6 inhibitors
EP3801500A4 (en) Inhibitors of sarm1
EP4337203A4 (en) INHIBITORS OF THE MENIN-MLL INTERACTION
EP4333821A4 (en) SARS-COV-2 INHIBITORS
DK3976597T3 (da) Småmolekylære inhibitorer af NF-KB-inducerende kinaser
DK4192813T3 (da) Inhibitorer af transglutaminaser
EP4225310A4 (en) HETEROARYL AMIDE INHIBITORS OF CD38
HUE056885T2 (hu) CREB-kötõ fehérjék inhibitorai
EP4305043A4 (en) Purification of sialooligosaccharides
EP4452967A4 (en) SARS-CoV-2 INHIBITORS
EP4247372A4 (en) PLASMA KALLICREIN INHIBITORS
HUE065395T2 (hu) Mikromûanyagok elválasztása
EP4495244A4 (en) MODIFIED GLUTAMINASE PROTEIN
EP4226919A4 (en) FERROPTOSIS INHIBITOR
EP4210694A4 (en) PLASMA KALLICREIN INHIBITORS
EP4178620A4 (en) PLASMA KALLICREIN INHIBITORS